Quantitative assessment of dynamic PET imaging data in cancer imaging

Magnetic Resonance Imaging

Volumn 30, Issue 9, 2012, Pages 1203-1215

  Muzi, Mark ^a,b   O'Sullivan, Finbarr ^c   Mankoff, David A ^a   Doot, Robert K ^a   Pierce, Larry A ^a   Kurland, Brenda F ^d   Linden, Hannah M ^e   Kinahan, Paul E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d Fred Hutchinson Cancer Research Center   (United States)

^e NONE   (United States)

Author keywords

Compartmental modeling; Dynamic PET CT; Multicenter clinical trials; Parametric imaging

Indexed keywords

16ALPHA FLUOROESTRADIOL F 18; 3' FLUOROTHYMIDINE F 18; ACETIC ACID C 11; CARBON 11; FLUORODEOXYGLUCOSE; RADIOPHARMACEUTICAL AGENT; THYMIDINE C 11; TRACER; UNCLASSIFIED DRUG; VERAPAMIL C 11;

ARTICLE; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; INFORMATION SCIENCE; METABOLIC RATE; METHODOLOGY; NEOPLASM; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT RESPONSE;

CALIBRATION; CLINICAL TRIALS AS TOPIC; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MEDICAL ONCOLOGY; MULTICENTER STUDIES AS TOPIC; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84867140348     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2012.05.008     Document Type: Article

References (48)

1. Boellaard R., Krak N.C., Hoekstra O.S., Lammertsma A.A. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 2004, 45:1519-1527.
2. Kinahan P.E., Fletcher J.W. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy. Semin Ultrasound CT MR 2010, 31:496-505.
3. Muzi M., Vesselle H., Grierson J.R., Mankoff D.A., Schmidt R.A., Peterson L., et al. Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer. J Nucl Med 2005, 46:274-282.
4. Muzi M., Spence A.M., O'Sullivan F., Mankoff D.A., Wells J.M., Grierson J.R., et al. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas. J Nucl Med 2006, 47:1612-1621.
5. Muzi M., Mankoff D.A., Link J.M., Shoner S., Collier A.C., Sasongko L., et al. Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans. J Nucl Med 2009, 50:1267-1275.
6. Takikawa S., Dhawan V., Spetsieris P., Robeson W., Chaly T., Dahl R., et al. Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology 1993, 188:131-136.
7. Olshen A.B., O'Sullivan F. Camouflaged deconvolution with application to blood curve modeling in FDG PET studies. J Am Stat Assoc 1997, 92:1293-1303.
8. Weinberg I.N., Huang S.C., Hoffman E.J., Araujo L., Nienaber C., Grover-McKay M., et al. Validation of PET-acquired input functions for cardiac studies. J Nucl Med 1988, 29:241-247.
9. Dunnwald L.K., Doot R.K., Specht J.M., Gralow J.R., Ellis G.K., Livingston R.B., et al. PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake. Clin Cancer Res 2011, 17:2400-2409.
10. Cunningham V.J., Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 1993, 13:15-23.
11. Wu H.M., Hoh C.K., Choi Y., Schelbert H.R., Hawkins R.A., Phelps M.E., et al. Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. J Nucl Med 1995, 36:1714-1722.
12. Schiepers C., Hoh C.K., Nuyts J., Wu C.H.M., Seltzer M.S., Phelps M.E., et al. Factor analysis: delineation of organ structures and automatic generation of in- and output functions in PET studies of prostate cancer. Nuclear Science Symposium Conference Record, 2001 IEEE 2001, 3:1454-1457. http://ieeexplore.ieee.org/xpl/articleDetails.jsp?reload=true&arnumber=1008611.
13. Liptrot M., Adams K.H., Martiny L., Pinborg L.H., Lonsdale M.N., Olsen N.V., et al. Cluster analysis in kinetic modelling of the brain: a noninvasive alternative to arterial sampling. Neuroimage 2004, 21:483-493.
14. Chen K., Chen X., Renaut R., Alexander G.E., Bandy D., Guo H., et al. Characterization of the image-derived carotid artery input function using independent component analysis for the quantitation of [18F] fluorodeoxyglucose positron emission tomography images. Phys Med Biol 2007, 52:7055-7071.
15. O'Sullivan F., Kirrane J., Muzi M., O'Sullivan J.N., Spence A.M., Mankoff D.A., et al. Kinetic quantitation of cerebral PET-FDG studies without concurrent blood sampling: statistical recovery of the arterial input function. IEEE Trans Med Imaging 2010, 29:610-624.
16. Green L.A., Gambhir S.S., Srinivasan A., Banerjee P.K., Hoh C.K., Cherry S.R., et al. Noninvasive methods for quantitating blood time-activity curves from mouse PET images obtained with fluorine-18-fluorodeoxyglucose. J Nucl Med 1998, 39:729-734.
17. Huang J., O'Sullivan F., O'Sullivan J.N., Mankoff D.A. Representation of the arterial input function using a Markov chain whole-body circulation model. IEEE Nuclear Science Symposium and Medical Imaging Conference 2011, [MIC12.M-203]. http://www.nss-mic.org/2011/program/ListProgramDB.asp?session=MIC12.M, C. Mokhtar (Ed.).
18. O'Sullivan F., Huang J., Fitzgerald N., Muzi M., Krohn K. A physiological model for representation of tracer activity in re-circulating venous and arterial blood. J Nucl Med 2011, 52:471P.
19. Shields A.F., Graham M.M., Kozawa S.M., Kozell L.B., Link J.M., Swenson E.R., et al. Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds. J Nucl Med 1992, 33:581-584.
20. Grierson J.R., Schwartz J.L., Muzi M., Jordan R., Krohn K.A. Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography. Nucl Med Biol 2004, 31:829-837.
21. Mankoff D.A., Shields A.F., Graham M.M., Link J.M., Eary J.F., Krohn K.A. Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis. J Nucl Med 1998, 39:1043-1055.
22. Wells J.M., Mankoff D.A., Eary J.F., Spence A.M., Muzi M., O'Sullivan F., et al. Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient results. Mol Imaging 2002, 1:145-150.
23. Krak N.C., Boellaard R., Hoekstra O.S., Twisk J.W., Hoekstra C.J., Lammertsma A.A. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial. Eur J Nucl Med Mol Imaging 2005, 32:294-301.
24. Westerterp M., Pruim J., Oyen W., Hoekstra O., Paans A., Visser E., et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging 2007, 34:392-404.
25. Wahl R.L., Jacene H., Kasamon Y., Lodge M.A. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009, 50(Suppl 1):122S-150S.
26. Weber W.A. Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 2005, 46:983-995.
27. Doot R.K., Scheuermann J.S., Christian P.E., Karp J.S., Kinahan P.E. Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT. Med Phys 2010, 37:6035-6046.
28. Oldendorf W.H. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol 1973, 224:1450-1453.
29. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M.H., Patlak C.S., Pettigrew K.D., et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977, 28:897-916.
30. Kenny L.M., Vigushin D.M., Al-Nahhas A., Osman S., Luthra S.K., Shousha S., et al. Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. Cancer Res 2005, 65:10104-10112.
31. Contractor K.B., Kenny L.M., Stebbing J., Rosso L., Ahmad R., Jacob J., et al. [18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel. Clin Cancer Res 2011, 17:7664-7672.
32. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983, 3:1-7.
33. Hunter G.J., Hamberg L.M., Alpert N.M., Choi N.C., Fischman A.J. Simplified measurement of deoxyglucose utilization rate. J Nucl Med 1996, 37:950-955.
34. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996, 16:834-840.
35. Meier P., Zierler K.L. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954, 6:731-744.
36. Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging 2005, 22:710-717.
37. Hawe D., Herńandez Ferńandez F., O'Suilleabháin L., Huang J., Wolsztynski E.O., Sullivan F. Kinetic analysis of dynamic positron emission tomography data using open-source image processing and statistical inference tools. Wiley Interdisciplinary Reviews: Computational Statistics 2012, 4:316-322.
38. O'Sullivan F. Imaging radiotracer model parameters in PET: a mixture analysis approach. IEEE Trans Med Imaging 1993, 12:399-412.
39. Choi Y., Hawkins R.A., Huang S.C., Gambhir S.S., Brunken R.C., Phelps M.E., et al. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. J Nucl Med 1991, 32:733-738.
40. Gunn R.N., Lammertsma A.A., Hume S.P., Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 1997, 6:279-287.
41. Ostergaard L., Johannsen P., Host-Poulsen P., Vestergaard-Poulsen P., Asboe H., Gee A.D., et al. Cerebral blood flow measurements by magnetic resonance imaging bolus tracking: comparison with [(15)O]H2O positron emission tomography in humans. J Cereb Blood Flow Metab 1998, 18:935-940.
42. Meikle S.R., Matthews J.C., Cunningham V.J., Bailey D.L., Livieratos L., Jones T., et al. Parametric image reconstruction using spectral analysis of PET projection data. Phys Med Biol 1998, 43:651-666.
43. Layfield D., Venegas J.G. Enhanced parameter estimation from noisy PET data: part I-methodology. Acad Radiol 2005, 12:1440-1447.
44. Kimura Y., Hsu H., Toyama H., Senda M., Alpert N.M. Improved signal-to-noise ratio in parametric images by cluster analysis. Neuroimage 1999, 9:554-561.
45. Guo H., Renaut R., Chen K., Reiman E. Clustering huge data sets for parametric PET imaging. Biosystems 2003, 71:81-92.
46. Murase K., Kuwabara H., Yasuhara Y., Evans A.C., Gjedde A. Mapping of change in cerebral glucose utilization using fluorine-18 fluorodeoxyglucose double injection and the constrained weighted-integration method. IEEE Trans Med Imaging 1996, 15:824-835.
47. O'Sullivan F. Metabolic images from dynamic positron emission tomography studies. Stat Methods Med Res 1994, 3:87-101.
48. O'Sullivan F., Muzi M., Spence A.M., Mankoff D.M., O'Sullivan J.N., Fitzgerald N., et al. Nonparametric residue analysis of dynamic PET data with application to cerebral FDG studies in normals. J Am Stat Assoc 2009, 104:556-571.